SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-000363
Filing Date
2023-01-03
Accepted
2023-01-03 16:31:06
Documents
13
Period of Report
2023-01-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm231320d1_8k.htm   iXBRL 8-K 23821
  Complete submission text file 0001104659-23-000363.txt   239357

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kprx-20230101.xsd EX-101.SCH 3286
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kprx-20230101_def.xml EX-101.DEF 26456
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kprx-20230101_lab.xml EX-101.LAB 36200
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kprx-20230101_pre.xml EX-101.PRE 25114
7 EXTRACTED XBRL INSTANCE DOCUMENT tm231320d1_8k_htm.xml XML 4853
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 23502562
SIC: 2834 Pharmaceutical Preparations